Evidence map›Paper›PMID 26707589›Full record

ReviewClimacteric : the journal of the International Menopause Society2016

Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?

D Edwards, N Panay

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Climacteric : the journal of the International Menopause Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 73 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03734523 completednot on this mapstarted 2021, after this paper: background citation

Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis

TypeobservationalSponsorVaginal Biome ScienceRan2021 to 2022Enrolled38ConditionsBacterial Vaginosis, Vaginal Flora ImbalanceArmsFlourish Vaginal Care System
NCT06900374 narecruitingnot on this mapstarted 2025, after this paper: background citation

RF-Vaginale : Randomised Phase III Trial Evaluating the Efficacy and Safety of Vaginal Radiofrequency in the Management of Vulvovaginal Atrophy and Dryness in Patients Treated for Breast Cancer

TypeinterventionalSponsorCentre Oscar LambretRan2025 to 2028Enrolled75ConditionsVaginal Dryness, Breast Cancer, Vulvovaginal AtrophyArmsGynWave-360, Local hydratation
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Let's talk about sex: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology: clinical recommendations after pelvic radiotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Article
  15. Review
  16. Modern methods of treating vaginal dryness and atrophy.Przeglad menopauzalny = Menopause review · 2026
    Review
  17. Article
  18. Review
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

D Edwardsa Claridges Barn , Charlbury Road, Chipping Norton , Oxon , UK ;
N Panayb Queen Charlotte's & Chelsea Hospital and Chelsea & Westminster Hospital, and Honorary Senior Lecturer, Imperial College , London , UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaginal dryness is a common condition that is particularly prevalent during and after the menopause, and is one of the symptoms of vulvovaginal atrophy/genitourinary syndrome of menopause. The impact of vaginal dryness on interpersonal relationships, quality of life, daily activities, and sexual function can be significant, but is frequently underestimated. Furthermore, barriers exist to treatment-seeking, and this condition is often underreported and undertreated. Greater education about vaginal dryness and the range of available treatments is essential to encourage more women to seek help for this condition. Personal lubricants and moisturizers are effective at relieving discomfort and pain during sexual intercourse for women with mild to moderate vaginal dryness, particularly those who have a genuine contraindication to estrogen, or who choose not to use estrogen. However, there is a distinction between lubricants and moisturizers, and notable differences between commercially available products. Women should be advised to choose a product that is optimally balanced in terms of both osmolality and pH, and is physiologically most similar to natural vaginal secretions. A series of recommendations for the use of vaginal lubricants and moisturizers, either on their own or in combination with systemic or topical hormone replacement therapy, is presented.

Indexed as

MenopauseAdministration, IntravaginalAtrophyDyspareuniaEstrogen Replacement TherapyFemaleHumansLubricantsQuality of LifeVaginaVaginal DiseasesVulvaWomen's HealthLubricantsCytotoxicitygenitourinary syndrome of menopauselubricantmoisturizerosmolalityvaginal drynessvulvovaginal atrophy

Identifiers

PMID26707589
PMCPMC4819835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.